Footer

    Download on the App StoreGet it on Google Play

    關於

    • 認識 VoiceTube
    • 學習服務介紹
    • 加入我們
    • 常見問題
    • 熱門搜尋主題
    • 企業英文培訓
    • 社群推廣分潤計畫

    服務總覽

    • 口說挑戰
    • 單字單句本
    • Hero 智能學習
    • Tutor 真人家教
    • Vclass 名師課程
    • Campus 教育版
    • 字典查詢
    • 匯入影片並生成字幕
    • 部落格

    精選頻道

    影片分級

    • A1 初級
    • A2 初級
    • B1 中級
    • B2 中高級
    • C1 高級
    • C2 高級

    隱私權˙條款˙
    ©2026 VoiceTube Corporation. All rights reserved

    agonist

    US /'ægənɪst/

    ・

    UK /'ægənɪst/

    A1 初級
    n.名詞促效藥 (和細胞受體結合產生生理性反應)

    影片字幕

    處方藥恐致衝動行為!BBC警告嚴峻後果! (Warning over prescription drugs causing impulsive behaviour | BBC News)

    06:56處方藥恐致衝動行為!BBC警告嚴峻後果! (Warning over prescription drugs causing impulsive behaviour | BBC News)
    • Brandon has Tourette's syndrome and had only just started secondary school when he was prescribed aripiprazole, a separate drug that's known as a partial dopamine agonist but also causes impulsive behaviour.

      情況從那裡變得更糟。

    • Brandon has Tourette syndrome and had only just started secondary school when he was prescribed aripiprazole, a separate drug that's known as a partial dopamine agonist but also causes impulsive behavior.

      Brandon 患有妥瑞氏症,剛上中學就被處方了 aripiprazole,這是一種單獨的藥物,被稱為部分多巴胺促效劑,但也會引起衝動行為。

    B1 中級

    這個藥能讓你變瘦嗎?🏃‍♂️💊 (Can This Drug Make You Thin? 🏃‍♂️💊)

    02:01這個藥能讓你變瘦嗎?🏃‍♂️💊 (Can This Drug Make You Thin? 🏃‍♂️💊)
    • It's a type of drug called a GLP1 agonist, which mimics the GLP1 hormone in your body.

      它是一種叫做 GLP1 促效劑的藥物,可以模仿你體內的 GLP1 荷爾蒙。

    • It's a type of drug called a GLP-1 agonist, which mimics the GLP-1 hormone in your body.

      它是一種叫做 GLP1 促效劑的藥物,可以模仿你體內的 GLP1 荷爾蒙。

    B2 中高級

    為什麼人人都在討論「猛健樂」?糖尿病藥變身減肥神器解析!(What is MOUNJARO? How it works and how this Diabetes Drug Became a Weight Loss Game-Changer!)

    10:13為什麼人人都在討論「猛健樂」?糖尿病藥變身減肥神器解析!(What is MOUNJARO? How it works and how this Diabetes Drug Became a Weight Loss Game-Changer!)
    • Unlike Ozempic, which was adapted from lizard spit—yes, lizard spit—Mounjaro was designed from the ground up by Eli Lilly to be a dual receptor agonist.

      這是基於老鼠研究的理論風險,但目前還沒有明確的人類證據。

    • Mounjaro was designed from the ground up by Eli Lilly to be a dual receptor agonist.

      猛健樂是由禮來公司從頭設計,作為一個雙重受體促效劑。

    B2 中高級

    休克性心臟衰竭與低心輸出量治療:血管活性藥物藥理學大剖析! (16) Pharmacology of vasoactive therapies used in low-output heart failure and cardiogenic shock.)

    40:34休克性心臟衰竭與低心輸出量治療:血管活性藥物藥理學大剖析! (16) Pharmacology of vasoactive therapies used in low-output heart failure and cardiogenic shock.)
    • Um, sort of an archetype agonist like phenylephrine is a clear squeeze-only alpha-1 agent.

      對於我的心臟衰竭研究員們,我快速地列出了所有可用的,嗯,腎上腺素受體。

    • Um, sort of an archetype agonist like phenylephrine is a clear squeeze-only alpha-1 agent.

      嗯,像苯腎上腺素這樣一個典型的激動劑,是一個明確的、只會收縮的 alpha-1 藥物。

    B1 中級

    我們意外發現的新型戒毒療法 (The New Addiction Treatment We Found By Mistake)

    07:55我們意外發現的新型戒毒療法 (The New Addiction Treatment We Found By Mistake)
    • In mice, rats, and even non-human primates, giving an animal a GLP-1 agonist reduces how much alcohol they drink and decreases the rewarding effects of drinking alcohol.

      在小鼠、大鼠,甚至非人類靈長類動物中,給予動物GLP-1受體激動劑會減少它們飲酒的量,降低飲酒的獎賞效應。

    • One of those few human studies found that one GLP-1 receptor agonist reduced alcohol use in patients who were obese, but not in patients who weren't.

      其中一項少數人類研究發現,GLP-1 受體激動劑減少了肥胖患者的酒精消耗,但對非肥胖患者則無影響。

    B2 中高級

    這款致命毒品人人都搶著用! (The deadly drug everyone is taking)

    09:36這款致命毒品人人都搶著用! (The deadly drug everyone is taking)
    • Glucagon-like peptide 1, or GLP-1, is a receptor agonist that many people have likely heard of.

      升糖素樣肽-1,也就是 GLP-1,是一種受體促效劑,很多人可能都聽過。

    B2 中高級

    研究顯示減重藥物可能也會降低罹癌風險! (Research shows weight-loss drugs may also reduce cancer risk)

    08:11研究顯示減重藥物可能也會降低罹癌風險! (Research shows weight-loss drugs may also reduce cancer risk)
    • But the data really support the idea that weight loss through a GLP-1 receptor agonist can not only help to prevent many of the obesity-related cancers, but

      但數據確實支持這樣的想法,也就是透過 GLP-1 受體促效劑減重,不僅能幫助預防許多與肥胖相關的癌症,

    • So, it's not surprising that, when we look at these large observational data sets, a GLP-1 receptor agonist, which can typically induce 15 to 20 percent or even greater weight loss, similar to what bariatric surgeries do, that these drugs can also reduce the risk of cancer.

      所以,當我們查看這些大型觀察性數據集時,GLP-1 受體促效劑通常能誘導 15% 到 20% 甚至更高的減重,這與減重手術的效果相似,是以這些藥物也能降低癌症風險,這並不令人意外。

    B1 中級

    PBS News Hour full episode, June 19, 2026

    56:47PBS News Hour full episode, June 19, 2026
    • But the data really support the idea that weight loss through a GLP-1 receptor agonist can not only help to prevent many of the obesity-related cancers, but
    • So, it's not surprising that, when we look at these large observational data sets, a GLP-1 receptor agonist, which can typically induce 15 to 20 percent or even greater weight loss, similar to what bariatric surgeries do, that these drugs can also reduce the risk of cancer.
    B1 中級